BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21757686)

  • 61. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
    He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
    Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
    [TBL] [Abstract][Full Text] [Related]  

  • 62. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
    Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor Cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Alkahtani S; Alarifi S; Tsichlis PN; Kampranis SC; Stournaras C
    Cell Physiol Biochem; 2018; 47(1):368-377. PubMed ID: 29772566
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
    Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
    Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN
    Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
    Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
    Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.
    Kamminga LM; Bystrykh LV; de Boer A; Houwer S; Douma J; Weersing E; Dontje B; de Haan G
    Blood; 2006 Mar; 107(5):2170-9. PubMed ID: 16293602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process.
    Pfau R; Tzatsos A; Kampranis SC; Serebrennikova OB; Bear SE; Tsichlis PN
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1907-12. PubMed ID: 18250326
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polycomb repressive complex 2 regulates normal development of the mouse heart.
    He A; Ma Q; Cao J; von Gise A; Zhou P; Xie H; Zhang B; Hsing M; Christodoulou DC; Cahan P; Daley GQ; Kong SW; Orkin SH; Seidman CE; Seidman JG; Pu WT
    Circ Res; 2012 Feb; 110(3):406-15. PubMed ID: 22158708
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
    Mitra D; Das PM; Huynh FC; Jones FE
    J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.
    Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ
    Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner.
    Wang T; Chen K; Zeng X; Yang J; Wu Y; Shi X; Qin B; Zeng L; Esteban MA; Pan G; Pei D
    Cell Stem Cell; 2011 Dec; 9(6):575-87. PubMed ID: 22100412
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
    Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
    Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
    Yu X; Wang J; Wu J; Shi Y
    Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16.
    Bai J; Chen J; Ma M; Cai M; Xu F; Wang G; Tao K; Shuai X
    DNA Cell Biol; 2014 Jun; 33(6):337-44. PubMed ID: 24588771
    [TBL] [Abstract][Full Text] [Related]  

  • 78. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
    Yan J; Ng SB; Tay JL; Lin B; Koh TL; Tan J; Selvarajan V; Liu SC; Bi C; Wang S; Choo SN; Shimizu N; Huang G; Yu Q; Chng WJ
    Blood; 2013 May; 121(22):4512-20. PubMed ID: 23529930
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
    McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cross talk between microRNA and epigenetic regulation in adult neurogenesis.
    Szulwach KE; Li X; Smrt RD; Li Y; Luo Y; Lin L; Santistevan NJ; Li W; Zhao X; Jin P
    J Cell Biol; 2010 Apr; 189(1):127-41. PubMed ID: 20368621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.